SHLP1
The first small humanin-like peptide — a mitochondrial-derived signaling molecule with chaperone-like cytoprotective activity.
A mitochondrial-derived peptide encoded within the MT-RNR2 gene that exhibits chaperone-like cytoprotective activity, protecting cells from oxidative stress and apoptosis.
Mechanism of action
Encoded within the 16S rRNA gene (MT-RNR2) of mitochondrial DNA. Demonstrates chaperone-like activity, stabilizing protein folding under stress conditions.
Primary uses
- Research: mitochondrial-derived peptide biology
- Cytoprotection research
- Aging and neurodegeneration research
Typical dosing
No established dosing.
Regulatory status
Not approved. Early-stage research peptide in the emerging MDP field.
References
- [pubmed] Cobb LJ, et al. "Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers." Aging. 2016;8(4):796-809.
Related peptides
This entry is for educational purposes only and does not constitute medical advice. Dosing information reflects published regulatory or research data and is not a recommendation. Many compounds described here are not approved for human use in the United States. Consult a licensed medical professional before considering any peptide therapy.